109
Participants
Start Date
June 30, 2012
Primary Completion Date
October 31, 2018
Study Completion Date
October 31, 2018
Erlotinib
Patients will be treated with erlotinib, 150 mg p.o., daily
Bevacizumab
Patients will be treated with bevacizumab 15 mg/kg i.v. on day 1 of each 3-week cycle (+/- 3 days)
Fondation du centre Pluridisciplinaire d'Oncologie (CePO), Lausanne
Geneva University Hospital, Geneva
Inselspital Bern, Bern
Onkologiezentrum Berner Oberland, Thun
University Hospital Basel, Basel
Kantonsspital Luzern, Lucerne
Istituto Oncologica della Svizzera Italiana, Bellinzona
University Hospital Zurich, Zurich
Kantonsspital Winterthur, Winterthur
Kantonsspital St. Gallen, Sankt Gallen
Hôpital de Marseille, Marseille
Centre Francois Baclesse, Caen
ICO - Girona, Girona
Ospedale San Gerardo, Monza
Hospital Grosshansdorf, Großhansdorf
Hospital Clinico Universitario San Carlos, Madrid
Hospital 12 de Octubre, Madrid
Istituto Oncologico Veneto IRCCS, Padua
Hospital General de Valencia, Valencia
Hospital La Fe, Valencia
Lungenklinik Hemer, Hemer
Thoraxklinik Heidelberg GmbH, Heidelberg
Universitätsklinikum Ulm, Ulm
Casa di Cura Maddalena, Palermo
University General Hospital of Heraklion, Heraklion
Papageorgias Hospital, Thessaloniki
St Vincent's University Hospital, Dublin
St. James's Hospital, Dublin
University Hospital Galway, Galway
Mid-Western Regional Hospital, Limerick
AMCCH, Tallaght
Policlinico Tor Vergata Roma, Roma
San Camillo Hospital, Roma
Policlinico Umberto, Roma
Hospital General Universitario Alicante, Alicante
ICO - Hospital Universitari Germans Trias i Pujol, Badalona
Hospital De La Santa Creu I Sant Pau, Barcelona
Vall d'Hebron University Hospital, Barcelona
Hospital Clínic Barcelona, Barcelona
ICO - Hospital Duran i Reynals, L'Hospitalet de Llobregat
Mid Essex Hospital Services NHS Trust, Chelmsford
Queen's Hospital, Burton-on-Trent
University Hospitals of Leicester, Leicester
Royal Marsden Hospital, London
Kent Oncology Centre, Maidstone
Christie Hospital Manchester, Manchester
Wythenshawe Hospital Manchester, Manchester
Wrexham Maelor Hospital, Wrexham
Spanish Lung Cancer Group
OTHER
ETOP IBCSG Partners Foundation
NETWORK